ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,668	3,053	5,140	2,578	3,752	8,499
Market Cap Growth	40.93%	-40.60%	99.40%	-31.29%	-55.85%	28.98%
Enterprise Value	2,962	2,537	4,852	2,204	3,278	7,904
Last Close Price	21.74	18.35	31.31	15.92	23.34	53.46
PE Ratio	16.40	13.48	-	-	-	-
Forward PE	34.36	35.90	27.40	-	-	-
PS Ratio	3.56	3.19	7.08	4.98	7.75	19.24
PB Ratio	4.46	4.17	11.91	6.44	6.94	13.56
P/TBV Ratio	5.18	4.98	14.04	6.44	6.94	13.58
P/FCF Ratio	19.60	19.42	308.70	-	-	-
P/OCF Ratio	19.52	19.36	307.78	-	-	-
EV/Sales Ratio	2.91	2.65	6.68	4.26	6.77	17.89
EV/EBITDA Ratio	28.49	25.33	-	-	-	-
EV/EBIT Ratio	32.80	30.11	-	-	-	-
EV/FCF Ratio	15.83	16.14	291.36	-	-	-
Debt / Equity Ratio	0.07	0.07	0.13	0.16	0.12	0.08
Debt / EBITDA Ratio	0.49	0.47	-	-	-	-
Debt / FCF Ratio	0.30	0.33	3.44	-	-	-
Asset Turnover	0.95	0.99	1.09	0.80	0.65	0.56
Inventory Turnover	8.30	13.33	18.53	51.22	29.44	35.81
Quick Ratio	2.67	2.18	2.13	3.82	6.10	6.44
Current Ratio	2.91	2.38	2.42	4.04	6.43	6.77
Return on Equity (ROE)	33.18%	38.89%	-14.73%	-45.89%	-28.75%	-42.47%
Return on Assets (ROA)	5.27%	5.44%	-6.86%	-21.70%	-14.37%	-18.66%
Return on Capital (ROIC)	7.77%	8.27%	-9.64%	-26.18%	-16.62%	-21.09%
Return on Capital Employed (ROCE)	10.10%	10.60%	-	-	-	-
Earnings Yield	6.06%	7.42%	-1.19%	-8.38%	-4.47%	-3.31%
FCF Yield	5.10%	5.15%	0.32%	-4.42%	-3.38%	-1.69%
Buyback Yield / Dilution	-1.10%	-1.55%	-1.32%	-0.74%	-2.01%	-6.88%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q